Evidence map›Paper›PMID 26019342›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivo.

Sudhir Sivakumaran, Ross A Cardarelli, Jamie Maguire, Matt R Kelley, Liliya Silayeva, Danielle H Morrow, Jayanta Mukherjee, Yvonne E Moore, Robert J Mather, Mark E Duggan and 5 more

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Article
  2. Article
  3. GABACellular and molecular neurobiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Constitutive KCC2 Cell- and Synapse-Specifically Regulates NMDA Receptor Activity in the Spinal Cord.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  13. Article
  14. Neuronal KActa pharmacologica Sinica · 2024
    Review
  15. The role ofJournal of pharmaceutical analysis · 2023
    Review
  16. Angiotensin ATCell reports · 2023
    Article
  17. Article
  18. Delaying the GABA Shift Indirectly Affects Membrane Properties in the Developing Hippocampus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sudhir SivakumaranDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111, Department of Biosciences, University of Helsinki, 00014 Helsinki, Finland.ORCID http://orcid.org/0000-0002-8586-0469
Ross A CardarelliAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111.
Jamie MaguireDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.ORCID http://orcid.org/0000-0002-4085-8605
Matt R KelleyDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.ORCID http://orcid.org/0000-0002-8010-6328
Liliya SilayevaAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111.
Danielle H MorrowDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.
Jayanta MukherjeeAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111.
Yvonne E MooreDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.
Robert J MatherAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111, AstraZeneca Neuroscience iMED, Cambridge, Massachusetts 02139, and.ORCID http://orcid.org/0000-0001-9105-7798
Mark E DugganAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111, AstraZeneca Neuroscience iMED, Cambridge, Massachusetts 02139, and.
Nicholas J BrandonAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111, AstraZeneca Neuroscience iMED, Cambridge, Massachusetts 02139, and.
John DunlopAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111, AstraZeneca Neuroscience iMED, Cambridge, Massachusetts 02139, and.
Stephen ZichaAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111, AstraZeneca Neuroscience iMED, Cambridge, Massachusetts 02139, and.ORCID http://orcid.org/0000-0001-5320-147X
Stephen J MossDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111, AstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111, Department of Neuroscience, Physiology and Pharmacology, University College, London, WC1E 6BT, United Kingdom Tarek.Deeb@tufts.edu Stephen.Moss@tufts.edu.
Tarek Z DeebAstraZeneca Tufts Laboratory for Basic and Translational Neuroscience, Boston, Massachusetts 02111, Tarek.Deeb@tufts.edu Stephen.Moss@tufts.edu.

Funding

Investigating the pathological consequences of seizure-induced activation of the HPA axisR01NS102937 · NINDS · TUFTS UNIVERSITY BOSTON · PI Jamie Lynn Maguire · 2017 to 2026
$4.2M
Mechanisms that determine Glutamine synthetase activity in the brainR01NS081986 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2012 to 2022
$3.7M
Constructing inhibitory synapsesR01NS051195 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2006 to 2014
$3.2M
Deficits in KCC2 activity and the pathophysiology of Status EpilepticusR01NS087662 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2014 to 2018
$2.0M
Investigating GABAergic control of the HPA axis in the co-morbidity of depressionR01NS073574 · NINDS · TUFTS UNIVERSITY BOSTON · PI MAGUIRE, JAMIE LYNN · 2011 to 2015
$1.7M
The role of ubiquitination in regulating GABA(A) receptor functional expressionR01NS056359 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2007 to 2010
$1.4M
Deficits in KCC2 activity and the pathophysiology of Autism spectrum disordersR21MH106954 · NIMH · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2015 to 2016
$454k
Impaired KCC2 function underlies pharmacoresistant seizuresR21NS080064 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2013 to 2014
$452k
NIMH NIH HHS R21 MH106954NINDS NIH HHS NS051195NINDS NIH HHS NS056359NINDS NIH HHS NS081735NINDS NIH HHS NS087662NINDS NIH HHS R01 NS051195NINDS NIH HHS R01 NS056359NINDS NIH HHS R01 NS073574NINDS NIH HHS R01 NS081986NINDS NIH HHS R01 NS087662NINDS NIH HHS R01 NS102937NINDS NIH HHS R21 NS080064NINDS NIH HHS R56 NS073574
6 · The paper itself

Abstract

GABA(A) receptors form Cl(-) permeable channels that mediate the majority of fast synaptic inhibition in the brain. The K(+)/Cl(-) cotransporter KCC2 is the main mechanism by which neurons establish low intracellular Cl(-) levels, which is thought to enable GABAergic inhibitory control of neuronal activity. However, the widely used KCC2 inhibitor furosemide is nonselective with antiseizure efficacy in slices and in vivo, leading to a conflicting scheme of how KCC2 influences GABAergic control of neuronal synchronization. Here we used the selective KCC2 inhibitor VU0463271 [N-cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide] to investigate the influence of KCC2 function. Application of VU0463271 caused a reversible depolarizing shift in E(GABA) values and increased spiking of cultured hippocampal neurons. Application of VU0463271 to mouse hippocampal slices under low-Mg(2+) conditions induced unremitting recurrent epileptiform discharges. Finally, microinfusion of VU0463271 alone directly into the mouse dorsal hippocampus rapidly caused epileptiform discharges. Our findings indicated that KCC2 function was a critical inhibitory factor ex vivo and in vivo.

Indexed as

AnimalsAnimals, NewbornCells, CulturedHEK293 CellsHippocampusHumansK Cl- CotransportersMembrane PotentialsMiceMice, Inbred C57BLOrgan Culture TechniquesRatsRats, Sprague-DawleySodium Potassium Chloride Symporter InhibitorsSymportersSynaptic TransmissionK Cl- CotransportersSodium Potassium Chloride Symporter InhibitorsSymporterschlorideGABAAKCC2seizuresslicesVU0463271

Identifiers

PMID26019342
PMCPMC4444547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.